loadpatents
Patent applications and USPTO patent grants for NIU; Deqiang.The latest application filed is for "benzo[b][1,8]naphthyridine acetic acid derivatives and methods of use".
Patent | Date |
---|---|
Benzo[b][1,8]naphthyridine Acetic Acid Derivatives And Methods Of Use App 20220251079 - ALLEN; Bryce K. ;   et al. | 2022-08-11 |
Oxoacridinyl Acetic Acid Derivatives And Methods Of Use App 20220227761 - ALLEN; Bryce K. ;   et al. | 2022-07-21 |
Heterocyclic Compounds And Uses Thereof App 20220218704 - Lee; Kwangho ;   et al. | 2022-07-14 |
2,4-disubstituted pyrimidines useful as kinase inhibitors Grant 11,351,168 - Singh , et al. June 7, 2 | 2022-06-07 |
Heterocyclic compounds and uses thereof Grant 11,096,942 - Lee , et al. August 24, 2 | 2021-08-24 |
MK2 inhibitors and uses thereof Grant 11,098,061 - Alexander , et al. August 24, 2 | 2021-08-24 |
Mk2 Inhibitors And Uses Thereof App 20210053984 - Alexander; Matthew David ;   et al. | 2021-02-25 |
Substituted 2,4-diaminopyrimidines as kinase inhibitors Grant 10,828,300 - Singh , et al. November 10, 2 | 2020-11-10 |
Heteroaryl compounds and uses thereof Grant 10,774,052 - D'Agostino , et al. September 15, 2 | 2020-09-15 |
Heterocyclic Compounds And Uses Thereof App 20200276194 - Lee; Kwangho ;   et al. | 2020-09-03 |
Protein kinase conjugates and inhibitors Grant 10,662,195 - Singh , et al. | 2020-05-26 |
Substituted pyrido[2,3-d]pyrimidines as inhibitors of protein kinases Grant 10,618,902 - D'Agostino , et al. | 2020-04-14 |
2,4-disubstituted pyrimidines useful as kinase inhibitors Grant 10,596,172 - Singh , et al. | 2020-03-24 |
MK2 inhibitors and uses thereof Grant 10,577,380 - Alexander , et al. | 2020-03-03 |
Heteroaryl Compounds And Uses Thereof App 20190375719 - D'Agostino; Laura Akullian ;   et al. | 2019-12-12 |
Mk2 Inhibitors And Uses Thereof App 20190375762 - Alexander; Matthew David ;   et al. | 2019-12-12 |
Heterocyclic compounds and uses thereof Grant 10,434,101 - Lee , et al. O | 2019-10-08 |
Heteroaryl Compounds And Uses Thereof App 20190218220 - D'Agostino; Laura Akullian ;   et al. | 2019-07-18 |
Heteroaryl Compounds And Uses Thereof App 20190192512 - Singh; Juswinder ;   et al. | 2019-06-27 |
Mk2 Inhibitors And Uses Thereof App 20190135835 - Alexander; Matthew David ;   et al. | 2019-05-09 |
Heteroaryl Compounds And Uses Thereof App 20190117650 - Singh; Juswinder ;   et al. | 2019-04-25 |
MK2 inhibitors and uses thereof Grant 10,253,040 - Alexander , et al. | 2019-04-09 |
Heteroaryl compounds and uses thereof Grant 10,189,794 - D'Agostino , et al. Ja | 2019-01-29 |
Heterocyclic Compounds And Uses Thereof App 20180353508 - Lee; Kwangho ;   et al. | 2018-12-13 |
MK2 inhibitors and uses thereof Grant 10,138,256 - Alexander , et al. Nov | 2018-11-27 |
Heteroaryl compounds and uses thereof Grant 10,081,606 - Lee , et al. September 25, 2 | 2018-09-25 |
Substituted pyrido[2,3-d]pyrimidines as inhibitors of protein kinases Grant 10,065,966 - D'Agostino , et al. September 4, 2 | 2018-09-04 |
2,4-disubstituted pyrimidines useful as kinase inhibitors Grant 10,010,548 - Singh , et al. July 3, 2 | 2018-07-03 |
Substituted 2,4-diaminopyrimidines as kinase inhibitors Grant 9,987,276 - Singh , et al. June 5, 2 | 2018-06-05 |
ERK inhibitors and uses thereof Grant 9,980,964 - Haq , et al. May 29, 2 | 2018-05-29 |
Heteroaryl Compounds And Uses Thereof App 20180072687 - Lee; Kwangho ;   et al. | 2018-03-15 |
Heteroaryl Compounds And Uses Thereof App 20180022713 - D'Agostino; Laura Akullian ;   et al. | 2018-01-25 |
Heterocyclic compounds and uses thereof Grant 9,867,824 - Lee , et al. January 16, 2 | 2018-01-16 |
Mutant-selective EGFR inhibitors and uses thereof Grant 9,868,723 - Lee , et al. January 16, 2 | 2018-01-16 |
ERK inhibitors and uses thereof Grant 9,796,700 - Haq , et al. October 24, 2 | 2017-10-24 |
MK2 inhibitors and uses thereof Grant 9,790,235 - Alexander , et al. October 17, 2 | 2017-10-17 |
Heteroaryl Compounds And Uses Thereof App 20170267685 - D'Agostino; Laura Akullian ;   et al. | 2017-09-21 |
Heteroaryl compounds and uses thereof Grant 9,765,038 - Lee , et al. September 19, 2 | 2017-09-19 |
Ligand-Directed Covalent Modification of Protein App 20170218353 - Petter; Russell C. ;   et al. | 2017-08-03 |
Erk Inhibitors And Uses Thereof App 20170210729 - Haq; Nadia ;   et al. | 2017-07-27 |
HCV protease inhibitors and uses thereof Grant 9,694,086 - Petter , et al. July 4, 2 | 2017-07-04 |
Heteroaryl compounds and uses thereof Grant 9,695,132 - D'Agostino , et al. July 4, 2 | 2017-07-04 |
Protein Kinase Conjugates and Inhibitors App 20170174691 - Singh; Juswinder ;   et al. | 2017-06-22 |
HCV protease inhibitors and uses thereof Grant 9,676,785 - Niu , et al. June 13, 2 | 2017-06-13 |
Substituted pyrido[2,3-d]pyrimidines as protein kinase inhibitors Grant 9,663,524 - D'Agostino , et al. May 30, 2 | 2017-05-30 |
Hcv Protease Inhibitors And Uses Thereof App 20170137463 - Niu; Deqiang ;   et al. | 2017-05-18 |
Erk Inhibitors And Uses Thereof App 20170137406 - Haq; Nadia ;   et al. | 2017-05-18 |
Mk2 Inhibitors And Uses Thereof App 20170114073 - Alexander; Matthew David ;   et al. | 2017-04-27 |
Heteroaryl Compounds And Uses Thereof App 20170100397 - Singh; Juswinder ;   et al. | 2017-04-13 |
ERK inhibitors and uses thereof Grant 9,561,228 - Haq , et al. February 7, 2 | 2017-02-07 |
Heterocyclic Compounds and Uses Thereof App 20170027937 - Lee; Kwangho ;   et al. | 2017-02-02 |
Protein kinase conjugates and inhibitors Grant 9,556,426 - Singh , et al. January 31, 2 | 2017-01-31 |
Macrocylic oximyl hepatitis C protease inhibitors Grant 9,526,769 - Sun , et al. December 27, 2 | 2016-12-27 |
ERK inhibitors and uses thereof Grant 9,504,686 - Haq , et al. November 29, 2 | 2016-11-29 |
Mutant-selective Egfr Inhibitors And Uses Thereof App 20160332994 - Lee; Kwangho ;   et al. | 2016-11-17 |
Hcv Protease Inhibitors And Uses Thereof App 20160326216 - Niu; Deqiang ;   et al. | 2016-11-10 |
Heteroaryl Compounds And Uses Thereof App 20160303121 - Singh; Juswinder ;   et al. | 2016-10-20 |
MK2 inhibitors and uses thereof Grant 9,458,175 - Alexander , et al. October 4, 2 | 2016-10-04 |
Hcv Protease Inhibitors And Uses Thereof App 20160243249 - Petter; Russell C. ;   et al. | 2016-08-25 |
HCV protease inhibitors and uses thereof Grant 9,422,333 - Niu , et al. August 23, 2 | 2016-08-23 |
Hcv Protease Inhibitors And Uses Thereof App 20160235805 - Petter; Russell C. ;   et al. | 2016-08-18 |
Mutant-selective EGFR inhibitors and uses thereof Grant 9,409,887 - Lee , et al. August 9, 2 | 2016-08-09 |
2,4-disubstituted pyrimidines as kinase inhibitors Grant 9,409,921 - Singh , et al. August 9, 2 | 2016-08-09 |
Heteroaryl Compounds And Uses Thereof App 20160221966 - D'Agostino; Laura Akullian ;   et al. | 2016-08-04 |
2,4-disubstituted pyrimidine compounds useful as kinase inhibtors Grant 9,375,431 - Lee , et al. June 28, 2 | 2016-06-28 |
Heteroaryl Compounds And Uses Thereof App 20160130236 - Lee; Kwangho ;   et al. | 2016-05-12 |
Heteroaryl compounds and uses thereof Grant 9,321,786 - D'Agostino , et al. April 26, 2 | 2016-04-26 |
Substituted 2,4-diaminopyrimidines as kinase inhibitors Grant 9,296,737 - Singh , et al. March 29, 2 | 2016-03-29 |
Erk Inhibitors And Uses Thereof App 20160082008 - Haq; Nadia ;   et al. | 2016-03-24 |
Mk2 Inhibitors And Uses Thereof App 20160075720 - Alexander; Matthew David ;   et al. | 2016-03-17 |
Heteroaryl Compounds And Uses Thereof App 20160046634 - D'Agostino; Laura Akullian ;   et al. | 2016-02-18 |
Heteroaryl compounds and uses thereof Grant 9,238,629 - Lee , et al. January 19, 2 | 2016-01-19 |
Erk Inhibitors And Uses Thereof App 20160002176 - Haq; Nadia ;   et al. | 2016-01-07 |
Mk2 Inhibitors And Uses Thereof App 20150376208 - ALEXANDER; Matthew David ;   et al. | 2015-12-31 |
Substituted 2,4-diaminopyrimidines as kinase inhibitors Grant 9,212,181 - Singh , et al. December 15, 2 | 2015-12-15 |
HCV protease inhibitors and uses thereof Grant 9,163,061 - Petter , et al. October 20, 2 | 2015-10-20 |
ERK inhibitors and uses thereof Grant 9,145,387 - Haq , et al. September 29, 2 | 2015-09-29 |
Heterocyclic Compounds And Uses Thereof App 20150246040 - Lee; Kwangho ;   et al. | 2015-09-03 |
Methods Of Treating A Bruton's Tyrosine Kinase Disease Or Disorder App 20150216865 - Westlin, III; William Frederick ;   et al. | 2015-08-06 |
Hcv Protease Inhibitors And Uses Thereof App 20150175657 - Niu; Deqiang ;   et al. | 2015-06-25 |
HCV protease inhibitors and uses thereof Grant 8,980,935 - Niu , et al. March 17, 2 | 2015-03-17 |
Heterocyclic compounds and uses thereof Grant 8,975,249 - Lee , et al. March 10, 2 | 2015-03-10 |
Quinoxalinyl derivatives Grant 8,962,551 - Niu , et al. February 24, 2 | 2015-02-24 |
Hcv Protease Inhibitors And Uses Thereof App 20150031106 - Niu; Deqiang ;   et al. | 2015-01-29 |
Mutant-selective Egfr Inhibitors And Uses Thereof App 20150025055 - Lee; Kwangho ;   et al. | 2015-01-22 |
Hcv Protease Inhibitors And Uses Thereof App 20140323465 - Niu; Deqiang ;   et al. | 2014-10-30 |
Heteroaryl Compounds And Uses Thereof App 20140296233 - D'Agostino; Laura Akullian ;   et al. | 2014-10-02 |
Quinoxalinyl macrocyclic hepatitis C virus serine protease inhibitors Grant 8,809,264 - Niu , et al. August 19, 2 | 2014-08-19 |
Erk Inhibitors And Uses Thereof App 20140228322 - Haq; Nadia ;   et al. | 2014-08-14 |
Mutant-selective EGFR inhibitors and uses thereof Grant 8,796,255 - Lee , et al. August 5, 2 | 2014-08-05 |
Heteroaryl Compounds And Uses Thereof App 20140213574 - Singh; Juswinder ;   et al. | 2014-07-31 |
HCV protease inhibitors and uses thereof Grant 8,778,877 - Niu , et al. July 15, 2 | 2014-07-15 |
HCV protease inhibitors and uses thereof Grant 8,741,837 - Niu , et al. June 3, 2 | 2014-06-03 |
2,4-disubstituted pyrimidines useful as kinase inhibitors Grant 8,710,222 - Singh , et al. April 29, 2 | 2014-04-29 |
Hcv Protease Inhibitors And Uses Thereof App 20130338062 - Niu; Deqiang ;   et al. | 2013-12-19 |
2,4-diaminopyrimidines useful as kinase inhibitors Grant 8,609,679 - Singh , et al. December 17, 2 | 2013-12-17 |
HCV protease inhibitors and uses thereof Grant 8,524,760 - Niu , et al. September 3, 2 | 2013-09-03 |
Macrocyclic hepatitis C virus serine protease inhibitors Grant 8,501,681 - Niu , et al. August 6, 2 | 2013-08-06 |
Heteroaryl Compounds And Uses Thereof App 20130165462 - Singh; Juswinder ;   et al. | 2013-06-27 |
2,4-disubstituted pyrimidines useful as kinase inhibitors Grant 8,450,335 - Singh , et al. May 28, 2 | 2013-05-28 |
Hcv Protease Inhibitors And Uses Thereof App 20130131105 - Petter; Russell C. ;   et al. | 2013-05-23 |
Heteroaryl Compounds And Uses Thereof App 20130072469 - Singh; Juswinder ;   et al. | 2013-03-21 |
Heteroaryl Compounds And Uses Thereof App 20130065879 - Singh; Juswinder ;   et al. | 2013-03-14 |
Heteroaryl Compounds And Uses Thereof App 20130065899 - Singh; Juswinder ;   et al. | 2013-03-14 |
Cyclic P3 tripeptide hepatitis C serine protease inhibitors Grant 8,377,872 - Gai , et al. February 19, 2 | 2013-02-19 |
Hcv Protease Inhibitors And Uses Thereof App 20130017991 - Niu; Deqiang ;   et al. | 2013-01-17 |
2,4-disubstituted pyrimidines useful as kinase inhibitors Grant 8,338,439 - Singh , et al. December 25, 2 | 2012-12-25 |
HCV protease inhibitors and uses thereof Grant 8,309,685 - Petter , et al. November 13, 2 | 2012-11-13 |
HCV protease inhibitors and uses thereof Grant 8,293,705 - Niu , et al. October 23, 2 | 2012-10-23 |
Pi3 Kinase Inhibitors And Uses Thereof App 20120258967 - Qiao; Lixin ;   et al. | 2012-10-11 |
Oximyl macrocyclic derivatives Grant 8,268,777 - Sun , et al. September 18, 2 | 2012-09-18 |
Macrocylic oximyl hepatitis C protease inhibitors Grant 8,268,776 - Sun , et al. September 18, 2 | 2012-09-18 |
Hcv Protease Inhibitors And Uses Thereof App 20120190614 - Niu; Deqiang ;   et al. | 2012-07-26 |
Mutant-selective Egfr Inhibitors And Uses Thereof App 20120157426 - Lee; Kwangho ;   et al. | 2012-06-21 |
Heterocyclic Compounds And Uses Thereof App 20120149687 - Lee; Kwangho ;   et al. | 2012-06-14 |
Heteroaryl Compounds And Uses Thereof App 20120149722 - Lee; Kwangho ;   et al. | 2012-06-14 |
Process for making macrocyclic oximyl hepatitis C protease inhibitors Grant 8,193,346 - Wagaw , et al. June 5, 2 | 2012-06-05 |
HCV protease inhibitors and uses thereof Grant 8,188,137 - Niu , et al. May 29, 2 | 2012-05-29 |
6-11 Bicyclic Ketolide Derivatives App 20120035352 - Or; Yat Sun ;   et al. | 2012-02-09 |
Ligand-directed Covalent Modification Of Protein App 20110269244 - Petter; Russell C. ;   et al. | 2011-11-03 |
Pi3 Kinase Inhibitors And Uses Thereof App 20110230476 - NIU; DEQIANG ;   et al. | 2011-09-22 |
Protein Kinase Conjugates and Inhibitors App 20110117073 - Singh; Juswinder ;   et al. | 2011-05-19 |
Heteroaryl Compounds And Uses Thereof App 20100249092 - Singh; Juswinder ;   et al. | 2010-09-30 |
Transforming Growth Factor Modulators App 20100166819 - Lee; Wen-Cherng ;   et al. | 2010-07-01 |
Arylalkoxyl hepatitis C virus protease inhibitors Grant 7,687,459 - Niu , et al. March 30, 2 | 2010-03-30 |
Hcv Protease Inhibitors And Uses Thereof App 20100069294 - Petter; Russell C. ;   et al. | 2010-03-18 |
Hcv Protease Inhibitors And Uses Thereof App 20100041674 - Niu; Deqiang ;   et al. | 2010-02-18 |
6-11 Bridged Oxime Erythromycin Derivatives App 20100041618 - Wang; Guoqiang ;   et al. | 2010-02-18 |
Hcv Protease Inhibitors And Uses Thereof App 20100041591 - Niu; Deqiang ;   et al. | 2010-02-18 |
Triazolyl macrocyclic hepatitis C serine protease inhibitors Grant 7,662,779 - Sun , et al. February 16, 2 | 2010-02-16 |
Heteroaryl Compounds and Uses Thereof App 20100029610 - Singh; Juswinder ;   et al. | 2010-02-04 |
6-11 Bicyclic Ketolide Derivatives App 20090324577 - Or; Yat Sun ;   et al. | 2009-12-31 |
Quinoxalinyl tripeptide hepatitis C virus inhibitors Grant 7,635,683 - Gai , et al. December 22, 2 | 2009-12-22 |
Hcv Protease Inhibitors And Uses Thereof App 20090306085 - Petter; Russell C. ;   et al. | 2009-12-10 |
Acylaminoheteroaryl hepatitis C virus protease inhibitors Grant 7,605,126 - Niu , et al. October 20, 2 | 2009-10-20 |
Phosphorus-containing hepatitis C serine protease inhibitors Grant 7,582,605 - Moore , et al. September 1, 2 | 2009-09-01 |
Oximyl Macrocyclic Derivatives App 20090191153 - Sun; Ying ;   et al. | 2009-07-30 |
Quinoxalinyl Derivatives App 20090180981 - Niu; Deqiang ;   et al. | 2009-07-16 |
Hcv Protease Inhibitors And Uses Thereof App 20090176858 - Niu; Deqiang ;   et al. | 2009-07-09 |
Process For Making Macrocyclic Oximyl Hepatitis C Protease Inhibitors App 20090156800 - Wagaw; Seble ;   et al. | 2009-06-18 |
Triazolyl Macrocyclic Hepatitis C Serine Protease Inhibitors App 20090047248 - Sun; Ying ;   et al. | 2009-02-19 |
Arylalkoxyl Hepatitis C Virus Protease Inhibitors App 20090041721 - Niu; Deqiang ;   et al. | 2009-02-12 |
Quinoxalinyl Macrocyclic Hepatitis C Virus Serine Protease Inhibitors App 20090005387 - Niu; Deqiang ;   et al. | 2009-01-01 |
Arylpiperidinyl And Arylpyrrolidinyl Tripeptide Hepatitis C Serine Protease Inhibitors App 20080317712 - Niu; Deqiang ;   et al. | 2008-12-25 |
Aza-tripeptide Hepatitis C Serine Protease Inhibitors App 20080287449 - Niu; Deqiang ;   et al. | 2008-11-20 |
Arylpiperidinyl And Arylpyrrolidinyl Macrocyclic Hepatitis C Serine Protease Inhibitors App 20080279821 - Niu; Deqiang ;   et al. | 2008-11-13 |
Aza-peptide Macrocyclic Hepatitis C Serine Protease Inhibitors App 20080274080 - Or; Yat Sun ;   et al. | 2008-11-06 |
Cyclic P3 Tripeptide Hepatitis C Serine Protease Inhibitors App 20080267916 - Gai; Yonghua ;   et al. | 2008-10-30 |
N-functionalized Amides As Hepatitis C Serine Protease Inhibitors App 20080267917 - Niu; Deqiang ;   et al. | 2008-10-30 |
6-11 Bridged Oxime Erythromycin Derivatives App 20080262208 - Wang; Guoqiang ;   et al. | 2008-10-23 |
3,6-bridged 9,12-oxolides Grant 7,407,942 - Or , et al. August 5, 2 | 2008-08-05 |
Macrocylic Oximyl Hepatitis C Protease Inhibitors App 20080181868 - Sun; Ying ;   et al. | 2008-07-31 |
Bicyclic 9a-azalide derivatives Grant 7,402,568 - Or , et al. July 22, 2 | 2008-07-22 |
Acylaminoheteroaryl hepatitis C virus protease inhibitors App 20080039470 - Niu; Deqiang ;   et al. | 2008-02-14 |
Phosphorus-containing hepatitis C serine protease inhibitors App 20080039375 - Moore; Joel D. ;   et al. | 2008-02-14 |
Quinoxalinyl tripeptide hepatitis C virus inhibitors App 20080032936 - Gai; Yonghua ;   et al. | 2008-02-07 |
Macrocyclic Hepatitis C Virus Serine Protease Inhibitors App 20080008681 - Niu; Deqiang ;   et al. | 2008-01-10 |
Quinoxalinyl Macrocyclic Hepatitis C Virus Serine Protease Inhibitors App 20070299078 - Niu; Deqiang ;   et al. | 2007-12-27 |
Macrocylic Oximyl Hepatitis C Protease Inhibitors App 20070281885 - Sun; Ying ;   et al. | 2007-12-06 |
Macrocyclic oximyl hepatitis C protease inhibitors App 20070281884 - Sun; Ying ;   et al. | 2007-12-06 |
6-11 Bicyclic Ketolide Derivatives App 20070244160 - Or; Yat Sun ;   et al. | 2007-10-18 |
3,6-Bridged 9,12-oxolides App 20070232554 - Or; Yat Sun ;   et al. | 2007-10-04 |
6-11 bicyclic ketolide derivatives Grant 7,273,853 - Or , et al. September 25, 2 | 2007-09-25 |
9N-substituted 6-11 bicyclic erythromycin derivatives Grant 7,265,094 - Qiu , et al. September 4, 2 | 2007-09-04 |
6-11 bicyclic ketolide derivatives Grant 7,189,704 - Niu , et al. March 13, 2 | 2007-03-13 |
6-11 Bridged oxime erythromycin derivatives App 20060252710 - Wang; Guoqiang ;   et al. | 2006-11-09 |
6-11 Bridged oxime erythromycin derivatives App 20060252712 - Wang; Guoqiang ;   et al. | 2006-11-09 |
6,11-bicyclic erythromycin derivatives Grant 7,129,221 - Or , et al. October 31, 2 | 2006-10-31 |
6-11 bicycle ketolide derivatives Grant 7,064,110 - Or , et al. June 20, 2 | 2006-06-20 |
6,11-4-Carbon bridged ketolides Grant 7,049,417 - Or , et al. May 23, 2 | 2006-05-23 |
Novel bicyclic 9a-azalide derivatives App 20060069048 - Or; Yat Sun ;   et al. | 2006-03-30 |
6-11 Bicyclic ketolide derivatives App 20050282758 - Niu, Deqiang ;   et al. | 2005-12-22 |
9N-substituted 6-11 bicyclic erythromycin derivatives App 20050171033 - Qiu, Yao-Ling ;   et al. | 2005-08-04 |
6-11 Bicyclic ketolide derivatives App 20050159370 - Or, Yat Sun ;   et al. | 2005-07-21 |
6-11 bicyclic ketolide derivatives Grant 6,878,691 - Or , et al. April 12, 2 | 2005-04-12 |
6-11 Bicyclic ketolide derivatives App 20050037982 - Or, Yat Sun ;   et al. | 2005-02-17 |
6,11-4-Carbon bridged erythromycin derivatives App 20050009763 - Or, Yat Sun ;   et al. | 2005-01-13 |
6,11-4-carbon bridged ketolides Grant 6,841,664 - Or , et al. January 11, 2 | 2005-01-11 |
6,11-4-Carbon bridged ketolides App 20040266998 - Or, Yat Sun ;   et al. | 2004-12-30 |
6-11 Bicyclic ketolide derivatives App 20040157787 - Or, Yat Sun ;   et al. | 2004-08-12 |
6,11-4-carbon bridged erythromycin derivatives Grant 6,753,318 - Or , et al. June 22, 2 | 2004-06-22 |
6,11-Bicyclic erythromycin derivatives App 20040053861 - Or, Yat Sun ;   et al. | 2004-03-18 |
6,11-4-carbon bridged ketolides App 20040023895 - Or, Yat Sun ;   et al. | 2004-02-05 |
11-O-substituted macrolides and their descladinose derivatives Grant 6,673,774 - Phan , et al. January 6, 2 | 2004-01-06 |
11-O-substituted ketolide derivatives Grant 6,670,331 - Phan , et al. December 30, 2 | 2003-12-30 |
Novel 11-O-substituted ketolide derivatives App 20030114395 - Phan, Ly Tam ;   et al. | 2003-06-19 |
11-O-substituted macrolides and their descladinose derivatives App 20030114396 - Phan, Ly Tam Phan ;   et al. | 2003-06-19 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.